Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
Clinical trial NCT02284555 · COMPLETED
Trial details
- NCT number
- NCT02284555
- Sponsor
- Destiny Pharma Plc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2014-11-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.